Hi everyone! I’m kaiba, founder of Atrix (atrix.finance), a Serum-based AMM project. My day-to-day role is being an Atrix protocol core developer and managing the rest of the team. Very excited to be part of this first official community discussion.
For context, Atrix allows projects to permisionlessly create Serum pools and farms, so new and existing projects can easily bootstrap liquidity on Serum.
We think this proposal adds a ton of value to the Serum and Solana ecosystem as a whole. Looking at Solana on-chain data, Serum is lagging behind some of the other top Solana projects in terms of TVL (as of Oct 7th, 2021), as shown in the screenshot below from DefiLlama - DeFi Dashboard.
Protocols such as Saber and Orca, which do not provide any liquidity to Serum, combined currently have multiples more value locked than Serum. Of course, these protocols provide value to the ecosystem as they are, but we think it would be better if Serum is a central source of liquidity on Solana, rather than multiple fragmented protocols. This would lead to better prices and execution for traders and Solana programs that swap tokens internally.
Therefore, incentivizing liquidity for projects that contribute to Serum’s liquidity (Atrix, Raydium, etc…) would benefit not just Serum, but more broadly most users of Solana in the form of better pricing.
Furthermore, we propose that it would also make sense to calculate the amount of SRM granted as a function of not just protocol TVL, but specifically protocol TVL which is deposited into Serum.
To illustrate:
Protocol A: $1B TVL, with 15% deposited into Serum ($150M).
Protocol B: $500M TVL, with 90% deposited into Serum ($450M).
Grants according to the current proposal:
Protocol A: $30M (~10% APY on 300M TVL cap)
Protocol B: $57M (~20% APY on 300M TVL cap)
Total granted: $87M
SRM USD value granted per USD of Serum liquidity:
Protocol A: $30M / $150M = $0.200
Protocol B: $57M / $450M = $0.127
In this example, Protocol B is providing 3x ($450M / $150M) more liquidity to Serum than Protocol A, but is receiving 37% less grant value per USD of Serum liquidity than Protocol A. In other words, Serum is spending 57% more on each unit of Serum liquidity provided by Protocol A compared to Protocol B. This is a suboptimal use of SRM when viewed through the lens of liquidity of Serum per SRM granted.
Furthermore, incentivizing liquidity more on Protocol B would lead to even more TVL on Serum, as Protocol B’s APYs would be increased (leading to more deposits) and as Protocol B deposits 90% of all TVL into Serum vs the 15% that Protocol A does.
We propose a more flexible calculation of SRM granted in proportion to Serum deposits, NOT protocol TVL which includes non-Serum liquidity (since that does not benefit Serum in any way):
Protocol A: $1B TVL, with 15% deposited into Serum ($150M).
Protocol B: $500M TVL, with 90% deposited into Serum ($450M).
Total Serum deposits: $600M
Grants given:
Total grant USD value available (for example): $90M
Protocol A: $22.5M ($150M / $600M * $90M)
Protocol B: $67.5M ($450M / $600M * $90M)
SRM USD value granted per USD of Serum liquidity:
Protocol A: $22.5M / $150M = $0.15
Protocol B: $67.5M / $450M = $0.15
Here, Serum isn’t suffering any losses due to inefficient grant distribution, and projects are treated fairly with respect to the amount of liquidity contributed to Serum.
Would love to hear any thoughts in response to this proposal!